Over a quarter ago |
Earnings
|
Reports Q1 revenue… Reports Q1 revenue $62.6M, two estimates $58.2M. Commenting on the results, Iv Culp, CEO, said, "Our results for the first quarter reflected sequential improvement as compared to the fourth quarter of fiscal 2022. However, as expected, sales and operating performance remained significantly pressured by slowing consumer demand in both the domestic mattress industry and the residential home furnishings industry. The impact of this industry softness on demand for our products is exacerbated by an excess of retail and manufacturer inventory that continues to delay the timing of shipments and new product rollouts. Operating performance was also affected by continued inflationary pressures, as well as reoccurring labor challenges within our mattress fabrics business and our Read Window Products business that resulted in increased employee training costs and operating inefficiencies during the quarter. We also had additional costs associated with increasing capacity at our new upholstery fabrics cut and sew facility in Haiti. Despite the ongoing headwinds, we maintained an unrelenting focus on working capital management, including inventory reduction, throughout the quarter. We ended the quarter with a higher cash position than expected, with $18.9 million in cash and investments and no outstanding borrowings. We also generated cash flow from operations of $5.3 million and free cash flow of $4.5 million. We continued to execute our product-driven strategy in each of our businesses, with an emphasis on design creativity and innovation. Following the lifting of COVID-related restrictions in China, our facilities resumed operations at normalized capacity in June, and we utilized our global manufacturing and sourcing platform throughout the quarter to meet the evolving needs of our customers. We also continued to build capacity at our new upholstery fabrics cut and sew facility in Haiti during the quarter. This facility is now fully staffed, with its weekly production output increasing as its employees gain more training and experience. As a company, we are enthusiastic about growing our near shore capacity in Haiti, with two facilities for cut and sewn mattress covers and one facility for cut and sewn upholstery kits. We believe this platform provides our customers with the agility and value they need for their business." ShowHide Related Items >><< - 06/30/22
- Culp, Inc. falls -15.0%
- 06/30/22
- Culp, Inc. falls -10.1%
- 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 06/30/22
- What You Missed On Wall Street On Thursday
- 06/30/22
- What You Missed On Wall Street This Morning
- 06/29/22
- Fly Intel: After-Hours Movers
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 06/29/22
- Xerox: CEO John Visentin has passed away, Steve Bandrowczak named Interim CEO
- 06/03/22
- Xerox appoints Joanne Collins Smee as EVP, president, Americas
- 05/25/22
- Xerox company CareAR enters metaverse partnership with Infosys
- 05/24/22
- Omnicom names Brian Clayton as Chief Data Privacy Officer
WBA Walgreens Boots Alliance - 06/28/22
- NeuroMetrix appoints Fluegel to board of directors
- 06/28/22
- Walgreens Boots Alliance ends strategic review, to keep ownership of Boots unit
- 06/28/22
- Walgreens Boots Alliance to retain ownership of Boots business, ends review
- 06/26/22
- Fly Intel: Top five weekend stock stories
- 05/05/22
- Ventas sees Q2 normalized FFO 69c-73c
- 04/25/22
- Ventas says Land & Buildings has withdrawn nomination of Litt for board
- 04/25/22
- Ventas shareholder Land & Buildings issues statement regarding its campaign
- 04/20/22
- Ventas says Glass Lewis recommends shareholders vote for directors
- 06/30/22
- Universal Health drops 7% to $99.00 after FY22 guidance lowered
- 04/26/22
- Universal Health falls -11.4%
- 04/26/22
- Universal Health falls -11.8%
- 04/25/22
- Universal Health drops 10% to $125.00 after Q1 EPS misses estimates
STZ.B Constellation Brands; also tag STZ - $294.70 /
+24.21 (+8.95%) - 04/08/22
- Constellation Brands CEO: Our products meet the needs of our consumers
- 04/07/22
- Constellation Brands announces accelerated stock buyback
- $232.96 /
-10.715 (-4.40%) - 06/30/22
- Constellation Brands enters agreement to eliminate Class B common stock
- 06/30/22
- Constellation Brands CEO 'pleased' with 'strong start' to fiscal year
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 04/12/22
- Constellation Brands director Fowden sells $1.8M in company shares
- 05/09/22
- Simon Property raises quarterly dividend 21.4%, authorizes $2B buyback program
- 02/07/22
- Simon Property reports occupancy was 93.4% at December 31, 2021
- 06/29/22
- SGH to acquire Stratus for $225M upfront payment, with up to $50M earnout
- 06/29/22
- SGH to acquire Stratus Technologies
- 05/02/22
- CreeLED files patent infringement suit against Star Headlight & Lantern
- 04/05/22
- SGH falls over 5% to $22.00 after Q2 earnings and guidance
- 02/03/22
- Sienna Senior Living forms joint venture with Sabra Health Care
- 02/03/22
- Extendicare to sell Esprit retirement communities for $307.5M
- 06/29/22
- Spirit Airlines intends to open, immediately adjourn Special Meeting of holders
- 06/29/22
- JetBlue tells crew Spirit will 'need to reconsider' if holders vote down deal
- 06/29/22
- JetBlue issues open letter to Spirit shareholders regarding Frontier deal
- 06/28/22
- Spirit Airlines: JetBlue offer doesn't address regulatory, board's concerns
- 05/11/22
- IBM, SAP announce expansion of technology partnership
- 05/10/22
- Qualtrics and SAP partner to bring more 'empathy' to contact center
- 05/04/22
- Google Cloud and SAP launch native integration between Workspace and S/4HANA C
- 04/22/22
- SAP backs FY22 cloud revenue view up 23%-26%
- 04/06/22
- RPT Realty acquires The Crossings shopping center for $104M
- 01/06/22
- RPT Realty announces $791M of investment activity in 2021
- $212.33 /
-25.17 (-10.60%) - 06/30/22
- RH falls -11.1%
- 06/30/22
- RH falls -8.2%
- 06/29/22
- RH falls 5% to $225 after cutting FY22 revenue guidance
- 06/02/22
- RH authorizes additional $2B in share repurchases
- 06/23/22
- Supreme Court strikes down New York gun carrying restrictions
- 06/02/22
- FBI reports 2.34M NICS firearm background checks in May
- 03/23/22
- AMMO announces delivery of donated ammunition to Ukraine
- 03/17/22
- AMMO announces plans to provide crypto currency capabilities for GunBroker.com
- 06/09/22
- Poshmark director sells $1.0M in common stock
- 06/09/22
- Poshmark set to join Russell 3000 Index
- 05/22/22
- Fly Intel: Top five weekend stock stories
- 04/12/22
- Affirm, Poshmark announce two-year extension of partnership
- 06/30/22
- Pfizer submits NDA to FDA for PAXLOVID
- 06/29/22
- Pfizer/BioNTech enter new $3.2B deal with U.S. government on COVID vaccines
- 06/28/22
- Pfizer and Roivant Sciences unveil Priovant Therapeutics
- 06/27/22
- Medtronic names Pfizer executive Lidia Fonseca as new director
- 02/28/22
- Omega Healthcare, MyndVR announce strategic partnership
- 02/02/22
- Omega Healthcare not providing FY22 earnings guidance amid pandemic
- 01/27/22
- Omega Healthcare authorizes new three-year $500M buyback program
- 06/30/22
- Novartis says data show tislelizumab significantly extended median OS in ESCC
- 06/24/22
- Novartis granted orphan status for malignant glioma treatment
- 06/24/22
- Novartis receives positive CHMP opinion for Scemblix
- 06/23/22
- Novartis says FDA grants accelerated approval for Tafinlar + Mekinist
- 05/17/22
- Nemaura Medical says MySugarWatch continues sugarBEAT awareness campaign
- 05/03/22
- MySugarWatch launches physician-focused ads in MIMS
- 01/13/22
- Nemaura Medical launches metabolic health program Miboko
- 01/10/22
- Nemaura Medical appoints Arash Ghadar to COO
- 06/29/22
- MillerKnoll jumps 6% to $29.70 after Q4 results beat estimates
- 06/29/22
- MillerKnoll re-establishing share repurchase program
- 06/29/22
- MillerKnoll reports Q4 adjusted gross margin 34.8% vs. 38.1% a year ago
- 06/29/22
- MillerKnoll 'confident' in synergies target of $120M within 3 years post close
- 06/30/22
- Meta will debut support for digital collectibles on Facebook
- 06/28/22
- Facebook tests new ways to access Groups and organize them, debuts channels
- 06/27/22
- Instagram introduces new ways to verify age
- 06/22/22
- Meta Platforms CEO: Metaverse will be a big theme for us over next decade
- 05/11/22
- Kite Realty Group increases quarterly dividend 5%
- 06/28/22
- Kraft Heinz announces 12-year virtual power purchase agreement with Repsol
- 05/26/22
- 3G Capital holds 7.9% of Kraft Heinz shares after share distribution
- 05/18/22
- Kraft Heinz CEO sells $11.5M in common stock
- 05/13/22
- CFTC settles enforcement action against Kraft, Mondelez
- 05/19/22
- Highwoods Properties sells FBI Tampa Field Office for $70.4M
- 05/09/22
- Highwoods Properties acquires two properties in Charlotte
- 03/07/22
- Highwoods Properties announces recent leasing activity in Tampa
- 05/13/22
- Figs falls -25.8%
- 05/13/22
- Figs falls -23.0%
- 05/13/22
- Figs falls -23.8%
- 05/12/22
- Figs reports active customers up 31.1% to 2M at March 31
- 05/19/22
- Equinix highlights latest progress on ESG commitments
- 03/18/22
- Equinix to acquire four Entel data centers for $705M
- 02/24/22
- Equinix names Nicole Collins as Chief Transformation Officer
- 02/07/22
- Equinix opens new IBX data center in Aschheim
- 06/28/22
- Digital Realty partners with HPE GreenLake
- 06/13/22
- Digital Realty, Mivne Real Estate form joint venture
- 06/06/22
- Digital Realty appoints Mary Hogan Preusse as chairman of board
- 05/12/22
- Digital Realty contracts for 158MW of renewable energy in California and Georgia
DCT Duck Creek Technologies - 06/28/22
- Duck Creek Technologies to acquire Prima XL, terms undisclosed
- 06/14/22
- Duck Creek Technologies highlights partnership with ODB by MCG
- 06/01/22
- Duck Creek Technologies joins Microsoft Azure Marketplace
- 05/11/22
- Duck Creek transitions Distinguished Programs to cloud native SaaS solution
- 06/30/22
- Culp, Inc. falls -15.0%
- 06/30/22
- Culp, Inc. falls -10.1%
- 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/24/22
- Coinbase Derivatives Exchange launching crypto derivatives product
- 06/23/22
- Coinbase says investigating connectivity issues
- 06/23/22
- Coinbase to begin sunsetting Coinbase Pro later this year
- 06/15/22
- Crypto names fall again as bitcoin extends decline to $20,000
- 06/14/22
- Ad market weaker now than 'last week, last month, last year,' says NBCU CEO
- 06/30/22
- Comcast's Xfinity Stream app launches on Apple TV 4K, Apple TV HD
- 06/22/22
- Magnite on watch following WSJ report on Netflix ad partnership considerations
- 06/14/22
- NBCUniversal CEO: New Orlando park Epic Universe to be anchored by Nintendo
- 06/14/22
- NBCUniversal 'works better' being part of Comcast, says NBCU CEO Shell
- 03/02/22
- Crown Castle announces proposed offering of senior notes
- 02/09/22
- Crown Castle increasing annual dividend 50% to 12c per share
- 01/06/22
- T-Mobile, Crown Castle expand relationship with tower, small cell agreement
- 06/27/22
- WeWork appoints Hurwitz to board of directors
- 06/25/22
- Pfizer, BioNTech announce data evaluating omicron-adapted vaccine candidates
- 06/23/22
- BioNTech receives PRIME designation for BNT211 in testicular cancer
- 06/23/22
- BioNTech starts construction on first mRNA vaccine facility in Africa
- 06/30/22
- Acuity Brands jumps 9% to $170.00 after Q3 results beat estimates
- 06/30/22
- Acuity Brands reports net cash from operating activities $165.7M
- 06/23/22
- Acuity Brands falls -5.2%
- 04/07/22
- Acuity Brands appoints Sankpal as SVP, Growth, Transformation
- 06/22/22
- AMD appoints Mathew Hein as chief strategy officer
- 06/12/22
- Fly Intel: Top five weekend stock stories
- 06/10/22
- AMD CEO: We're laser focused on technology leadership
- 06/09/22
- AMD announces Technology and Product Portfolio updates
- 02/15/22
- Acadia Realty Trust raises quarterly dividend 20% to 18c per share
WBA Walgreens Boots Alliance - 07/01/22 Morgan Stanley
- Walgreens consensus needs to come down by more than 11%, says Morgan Stanley
- 07/01/22 Credit Suisse
- Walgreens Boots Alliance price target lowered to $43 from $52 at Credit Suisse
- 07/01/22 Deutsche Bank
- Walgreens Boots Alliance price target lowered to $44 from $46 at Deutsche Bank
- 07/01/22 Truist
- Walgreens Boots Alliance price target lowered to $42 from $50 at Truist
- 06/29/22 Evercore ISI
- Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
- 06/22/22 Piper Sandler
- Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 06/03/22 Oppenheimer
- Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
- 04/12/22 H.C. Wainwright
- BioNTech price target lowered to $298 from $339 at H.C. Wainwright
- 04/11/22 H.C. Wainwright
- H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
- 04/05/22 Canaccord
- BioNTech price target lowered to $300 from $450 at Canaccord
- $232.96 /
-10.715 (-4.40%) - 07/01/22 Credit Suisse
- Constellation Brands price target lowered to $292 from $295 at Credit Suisse
- 07/01/22 Deutsche Bank
- Constellation Brands price target lowered to $240 from $248 at Deutsche Bank
- 06/28/22 Goldman Sachs
- Constellation Brands to beat sales estimates in Q1, says Goldman Sachs
- 06/28/22 Goldman Sachs
- Boston Beer downgraded to Sell from Neutral at Goldman Sachs
STZ.B Constellation Brands; also tag STZ - $294.70 /
+24.21 (+8.95%) - 05/18/22 Bernstein
- Bernstein upgrades Monster Beverage to Outperform, raises price target to $110
- 01/04/22 Wells Fargo
- Constellation Brands price target raised to $300 from $265 at Wells Fargo
- 07/01/22 Mizuho
- Universal Health price target lowered to $121 from $153 at Mizuho
- 06/16/22 Loop Capital
- Loop starts Universal Health at Hold on behavioral health staffing concerns
- 06/16/22 Loop Capital
- Universal Health initiated with a Hold at Loop Capital
- 05/03/22 Mizuho
- Universal Health price target lowered to $153 from $164 at Mizuho
- $212.33 /
-25.17 (-10.60%) - 07/01/22 Citi
- RH shares offer 'significantly more upside than downside,' says Citi
- 06/30/22 Morgan Stanley
- RH price target lowered to $350 from $385 at Morgan Stanley
- 06/30/22 Jefferies
- RH price target lowered to $400 from $520 at Jefferies
- 06/30/22 Wedbush
- RH price target lowered to $274 from $315 at Wedbush
- 06/30/22 Northland
- AMD upgraded to Outperform at Northland following multiple compression
- 06/30/22 Northland
- AMD upgraded to Outperform from Market Perform at Northland
- 06/29/22 BofA
- AMD price target lowered to $110 from $160 at BofA
- 06/22/22 Morgan Stanley
- AMD resumed with an Overweight at Morgan Stanley
- 06/29/22 Raymond James
- Poshmark downgraded to Market Perform from Outperform at Raymond James
- 06/28/22 Stifel
- Poshmark price target raised to $13 from $12 at Stifel
- 06/09/22 Goldman Sachs
- Poshmark price target lowered to $12 from $14 at Goldman Sachs
- 06/01/22 JMP Securities
- Poshmark resumed with Market Perform from Outperform at JMP Securities
- 06/30/22 William Blair
- William Blair upgrades ShotSpotter with 60% upside over two years
- 06/30/22 William Blair
- ShotSpotter upgraded to Outperform from Market Perform at William Blair
- 02/23/22 Lake Street
- ShotSpotter price target lowered to $29 from $42 at Lake Street
- 12/21/21 JMP Securities
- ShotSpotter resumed with a Market Perform at JMP Securities
- 07/01/22 Credit Suisse
- SAP remains top pick in European software at Credit Suisse
- 06/30/22 Exane BNP Paribas
- SAP downgraded to Neutral on near-term risks at BNP Paribas
- 06/30/22 Exane BNP Paribas
- SAP downgraded to Neutral from Outperform at Exane BNP Paribas
- 06/20/22 Jefferies
- SAP price target lowered to EUR 110 from EUR 120 at Jefferies
- 07/01/22 Mizuho
- Ventas price target lowered to $61 from $65 at Mizuho
- 06/30/22 Jefferies
- Ventas upgraded to Buy from Hold at Jefferies
- 06/22/22 Credit Suisse
- Ventas initiated with an Outperform at Credit Suisse
- 06/03/22 Capital One
- Ventas reinstated with Overweight from Equalweight at Capital One
- 06/30/22 Jefferies
- Crown Castle upgraded to Buy from Hold at Jefferies
- 06/28/22 Deutsche Bank
- Crown Castle downgraded to Hold from Buy at Deutsche Bank
- 06/02/22 Wells Fargo
- Wells Fargo cuts Crown Castle to Underweight as growth gap versus peers widens
- 06/02/22 Wells Fargo
- Crown Castle downgraded to Underweight from Equal Weight at Wells Fargo
- 07/01/22 Wells Fargo
- Chanos' argument on data centers 'unoriginal' and 'misguided,' says Wells Fargo
- 06/30/22 Jefferies
- Equinix upgraded to Buy from Hold at Jefferies
- 06/30/22 JPMorgan
- JPMorgan remains positive on data center industry after short call
- 06/29/22 Cowen
- Cowen 'largely disagrees' with Chanos' short thesis on data centers
- 06/30/22 Jefferies
- Digital Realty upgraded to Buy from Hold at Jefferies
- 06/30/22 Jefferies
- Acadia Realty Trust downgraded to Hold at Jefferies among REIT rating shake-up
- 06/30/22 Jefferies
- Acadia Realty Trust downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Acadia Realty Trust price target lowered to $23 from $25 at Compass Point
- 06/21/22 Truist
- Acadia Realty Trust price target lowered to $23 from $27 at Truist
- 06/30/22 Jefferies
- Brixmor downgraded to Underperform from Hold at Jefferies
- 06/22/22 Credit Suisse
- Brixmor initiated with an Outperform at Credit Suisse
- 06/22/22 JPMorgan
- Brixmor upgraded to Overweight from Neutral at JPMorgan
- 06/21/22 Truist
- Brixmor price target lowered to $26 from $29 at Truist
- 06/30/22 Jefferies
- Kite Realty Group downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Kite Realty Group price target lowered to $27 from $30 at Compass Point
- 01/13/22 Baird
- Kite Realty Group upgraded to Outperform from Neutral at Baird
- 10/27/21 Jefferies
- Kite Realty Group initiated with a Buy at Jefferies
- 06/30/22 Jefferies
- Omega Healthcare downgraded to Hold from Buy at Jefferies
- 06/14/22 Truist
- Omega Healthcare price target lowered to $30 from $33 at Truist
- 06/03/22 Capital One
- Omega Healthcare reinstated with an Equalweight at Capital One
- 04/26/22 Barclays
- Omega Healthcare initiated with an Equal Weight at Barclays
- 06/30/22 Jefferies
- Sabra Health Care downgraded to Hold from Buy at Jefferies
- 06/03/22 Capital One
- Sabra Health Care reinstated with an Equalweight at Capital One
- 05/25/22 Mizuho
- Sabra Health Care upgraded to Buy from Neutral at Mizuho
- 06/30/22 Jefferies
- RPT Realty downgraded to Hold from Buy at Jefferies
- 06/22/22 Credit Suisse
- RPT Realty initiated with an Outperform at Credit Suisse
- 10/14/21 Mizuho
- RPT Realty initiated with a Buy at Mizuho
- 10/06/21 Deutsche Bank
- RPT Realty price target lowered to $16 from $17 at Deutsche Bank
- 06/30/22 Jefferies
- Simon Property downgraded to Hold at Jefferies among REIT rating shake-up
- 06/30/22 Jefferies
- Simon Property downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Simon Property price target lowered to $160 from $200 at Compass Point
- 06/03/22 Truist
- Simon Property price target lowered to $130 from $155 at Truist
- 06/30/22 Jefferies
- Highwoods Properties downgraded to Hold from Buy at Jefferies
- 06/30/22 Truist
- Highwoods Properties price target lowered to $42 from $48 at Truist
- 06/22/22 Credit Suisse
- Highwoods Properties initiated with a Neutral at Credit Suisse
- 04/22/22 Mizuho
- Highwoods Properties initiated with a Neutral at Mizuho
- 06/29/22 Deutsche Bank
- Novartis price target lowered to CHF 75 from CHF 80 at Deutsche Bank
- 05/13/22 Piper Sandler
- Point Biopharma price target lowered to $14 from $17 at Piper Sandler
- 05/13/22 Jefferies
- Roche downgraded to Hold from Buy at Jefferies
- 04/22/22 Citi
- Xerox price target lowered to $15 from $17 at Citi
- 02/24/22 Gordon Haskett
- Icahn could take Xerox private 'without breaking a sweat,' says Gordon Haskett
- 11/23/21 Gordon Haskett
- Gordon Haskett highlights Tyson, Xerox after Ericsson-Vonage deal
- 07/02/21 Bernstein
- HP plus Xerox 'consolidation math compelling,' says Bernstein
- 06/22/22 BMO Capital
- Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
- 05/26/22 UBS
- UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
- 05/26/22 UBS
- Kraft Heinz downgraded to Sell from Neutral at UBS
- 05/09/22 BofA
- Coca-Cola, Kraft Heinz added to 'US 1' list at BofA
- 04/19/22 Berenberg
- Tesco price target lowered to 320 GBp from 327 GBp at Berenberg
- 10/20/21 Berenberg
- Tesco price target raised to 308 GBp from 280 GBp at Berenberg
- 10/13/21 Morgan Stanley
- Tesco price target raised to 318 GBp from 303 GBp at Morgan Stanley
- 10/07/21 JPMorgan
- Tesco price target raised to 330 GBp from 300 GBp at JPMorgan
- 06/27/22 Goldman Sachs
- Coinbase downgraded to Sell from Neutral at Goldman Sachs
- 06/23/22 Redburn
- Coinbase downgraded to Neutral from Buy at Redburn
- 06/22/22 BTIG
- Coinbase price target lowered to $290 from $380 at BTIG
- 06/22/22 Mizuho
- Coinbase trading patterns show potential 'crypto fatigue,' says Mizuho
- 07/01/22 Daiwa
- Comcast initiated with an Outperform at Daiwa
- 06/29/22 TD Securities
- Comcast price target lowered to $60 from $65 at TD Securities
- 06/28/22 Scotiabank
- Comcast assumed with an Outperform at Scotiabank (yesterday)
- 06/21/22 Truist
- Magnite well positioned to partner with Netflix, says Truist
- 05/23/22 Raymond James
- Electronic Arts moves 'somewhat unexpected,' says Raymond James
- 04/14/22 Oppenheimer
- Comcast price target lowered to $60 from $75 at Oppenheimer
- 03/23/22 Craig-Hallum
- ComScore poised for share gains in local measurement, says Craig-Hallum
- 06/29/22 Raymond James
- Figs initiated with a Strong Buy at Raymond James
- 05/16/22 Barclays
- Figs price target lowered to $13 from $34 at Barclays
- 05/16/22 Oppenheimer
- Figs price target lowered to $22 from $45 at Oppenheimer
- 05/16/22 BofA
- Figs downgraded to Neutral from Buy at BofA
- 06/27/22 Evercore ISI
- Spirit Airlines price target raised to $28 from $25 at Evercore ISI
- 06/23/22 Raymond James
- Frontier Group upgraded to Outperform from Market Perform at Raymond James
- 06/10/22 JPMorgan
- Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
- 05/05/22 Deutsche Bank
- Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
- 06/27/22 Evercore ISI
- JetBlue price target lowered to $10 from $13 at Evercore ISI
- 04/26/22 JPMorgan
- JetBlue double downgraded to Underweight from Overweight at JPMorgan
- 06/27/22 Evercore ISI
- Frontier Group price target lowered to $15 from $20 at Evercore ISI
- 04/11/22 MKM Partners
- JetBlue upgraded to Neutral at MKM Partners on valuation
- 06/30/22 Needham
- SGH price target lowered to $40 from $45 at Needham
- 06/30/22 Stifel
- SGH price target lowered to $32 from $45 at Stifel
- 06/30/22 Deutsche Bank
- SGH price target lowered to $32 from $40 at Deutsche Bank
- 06/30/22 Barclays
- SGH price target lowered to $22 from $30 at Barclays
- 06/30/22 JMP Securities
- Meta Platforms price target lowered to $240 from $265 at JMP Securities
- 06/29/22 JPMorgan
- Meta Platforms price target lowered to $225 from $275 at JPMorgan
- 06/22/22 BofA
- Meta's Creator commission delay impacts 2023 revenue less than 1%, says BofA
- 06/16/22 Truist
- France ruling on Meta incremental positive for Criteo, says Truist
- 07/01/22 Oppenheimer
- Acuity Brands delivers 'strong organic beat' in Q3, says Oppenheimer
- 07/01/22 Baird
- Acuity Brands price target raised to $190 from $188 at Baird
- 06/27/22 Credit Suisse
- Acuity Brands price target lowered to $211 from $241 at Credit Suisse
- 06/23/22 William Blair
- William Blair downgrades Acuity Brands after survey points to weaker demand
- 06/30/22 EF Hutton
- AMMO shares should be bought 'aggressively,' says EF Hutton
- 08/17/21 Lake Street
- AMMO price target raised to $12 at Lake Street after beat and raise report
DCT Duck Creek Technologies - 07/01/22 JMP Securities
- Duck Creek downgraded to Market Perform from Outperform at JMP Securities
- 06/30/22 BofA
- Duck Creek Technologies downgraded to Neutral from Buy at BofA
- 06/30/22 BofA
- Duck Creek Technologies downgraded to Neutral from Buy at BofA
- 06/30/22 RBC Capital
- Duck Creek Technologies price target lowered to $18 from $25 at RBC Capital
- 03/29/22 H.C. Wainwright
- Nemaura Medical initiated with a Buy at H.C. Wainwright
- 07/12/21 Ascendiant
- Nemaura Medical price target raised to $17 from $15 at Ascendiant
- 06/30/22 Craig-Hallum
- MillerKnoll price target lowered to $50 from $60 at Craig-Hallum
- 04/21/22
- Xerox still sees 2022 revenue at least $7.1B, consensus $7.05B
- 04/21/22
- Xerox reports Q1 adjusted EPS (12c), consensus 13c
- 01/25/22
- Xerox sees FY22 revenue 'at least $7.1B in actual currency,' consensus $7B
- 01/25/22
- Xerox reports Q4 adjusted EPS 34c, consensus 33c
WBA Walgreens Boots Alliance - 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 06/30/22
- Walgreens Boots Alliance reports Q3 adjusted EPS 96c, consensus 92c
- 06/29/22
- Notable companies reporting before tomorrow's open
- 05/05/22
- Ventas reports Q1 normalized FFO 79c, consensus 77c
- 02/17/22
- Ventas sees Q1 normalized FFO 76c-80c, consensus 71c
- 02/17/22
- Ventas reports Q4 normalized FFO 73c, consensus 71c
- 04/28/22
- Frontier Group sees Q2 pre-tax margin between 1%-5%
- 04/28/22
- Frontier Group reports Q1 EPS (56c), consensus (43c)
- 02/07/22
- Frontier Group is not providing guidance
- 02/07/22
- Frontier Group is not providing guidance
- 06/30/22
- Universal Health cuts FY22 adjusted EPS view to $9.60-$10.40 from $11.90-$12.90
- 06/30/22
- Universal Health sees Q2 adjusted EPS $2.05-$2.15, consensus $2.79
- 04/25/22
- Universal Health reports Q1 adjusted EPS $2.15, consensus $2.46
- 04/25/22
- Notable companies reporting after market close
- $232.96 /
-10.715 (-4.40%) - 06/30/22
- Constellation Brands affirms 2023 comparable EPS view $11.20-$11.50
- 06/30/22
- Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.90
- 06/30/22
- Constellation Brands reports Q1 comparable EPS $2.66, consensus $2.52
- 02/22/22
- ShotSpotter raises FY22 revenue view to $81M-$83M from $71M-$73M
- 02/22/22
- ShotSpotter reports Q4 adjusted EPS (12c), consensus 0c
- 05/09/22
- Simon Property raises FY22 comparable FFO/share view to $11.60-$11.75
- 05/09/22
- Simon Property reports Q1 FFO/share $2.78, consensus $2.73
- 02/07/22
- Simon Property sees FY22 FFO $11.50-$11.70, consensus $11.69
- 02/07/22
- Simon Property reports Q4 FFO $3.09, consensus $2.88
- 06/29/22
- SGH sees Q4 adjusted EPS 65c, plus or minus 10c, consensus 84c
- 06/29/22
- SGH reports Q3 adjusted EPS 87c, consensus 75c
- 04/05/22
- SGH sees Q3 EPS 67c-83c, consensus 71c
- 04/05/22
- SGH reports Q2 EPS 87c, consensus 72c
- 05/04/22
- Sabra Health Care reports Q1 FFO 39c, consensus 38c
- 05/04/22
- Spirit Airlines sees FY22 other capital expenditures $240M
- 05/04/22
- Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B
- 05/04/22
- Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58)
- 04/22/22
- SAP reports Q1 non-IFRS EPS EUR 1.00 vs EUR 1.40 last year
- 01/27/22
- SAP reports Q4 non-IFRS EPS EUR 1.86 vs EUR 1.70 last year
- 01/13/22
- SAP sees FY22 cloud revenue EUR 11.55B-11.85B, up 23%-26%
- 01/13/22
- SAP reports Q4 EIPS EUR 1.86, up 10%
- $212.33 /
-25.17 (-10.60%) - 06/29/22
- RH cuts FY22 revenue growth view to down 5% to down 2%
- 06/29/22
- RH sees Q2 revenue down 3% to down 1%
- 06/02/22
- RH sees FY22 revenue flat to up 2%, consensus $4.01B
- 06/02/22
- RH sees Q2 revenue down (1%)-(3%), consensus $1.04B
- 06/29/22
- AMMO sees FY 23 revenue $300M -$310M, consensus $311.77M
- 06/29/22
- AMMO reports FY22 EPS 53c, consensus 35c
- 02/14/22
- AMMO backs FY22 revenue view of $250M, consensus $246.4M
- 02/14/22
- AMMO reports Q3 EPS 14c, consensus 10c
- 05/12/22
- Poshmark sees Q2 revenue $86M-$88M, consensus $89.83M
- 05/12/22
- Poshmark reports Q1 EPS (18c), consensus (22c)
- 05/12/22
- Notable companies reporting after market close
- 03/22/22
- Poshmark sees Q1 revenue $86M-$88M, consensus $90.53M
- 05/03/22
- Pfizer cuts FY22 adjusted EPS view to $6.25-$6.45 from $6.35-$6.55
- 05/03/22
- Pfizer reports Q1 adjusted EPS $1.62, consensus $1.47
- 05/02/22
- Notable companies reporting before tomorrow's open
- 05/02/22
- Omega Healthcare reports Q1 Adjusted FFO 74c, consensus 68c
- 02/02/22
- Omega Healthcare reports Q4 AFFO 77c, consensus 82c
- 04/26/22
- Novartis sees 2022 core operating income to grow mid single digit
- 04/26/22
- Novartis reports Q1 core EPS $1.46, consensus $1.46
- 02/02/22
- Novartis sees 2022 sales, core operating income up mid single digit
- 02/02/22
- Novartis reports Q4 core EPS $1.40 vs. $1.34 last year
- 06/30/22
- Nemaura Medical reports 2022 EPS (59c), consensus (58c)
- 02/14/22
- Nemaura Medical reports Q3 EPS (15c), two estimates (14c)
- 06/29/22
- MillerKnoll sees Q1 EPS 32c-38c, consensus 35c
- 06/29/22
- MillerKnoll reports Q4 adjusted EPS 58c, consensus 47c
- 03/29/22
- MillerKnoll sees Q4 EPS 46c-52c, consensus 49c
- 03/29/22
- MillerKnoll reports Q3 adjusted EPS 28c, consensus 27c
- 02/14/22
- Kite Realty Group sees FY22 adjusted FFO $1.69-$1.75, consensus $1.62
- 02/14/22
- Kite Realty Group reports Q4 adjusted FFO 43c, consensus 37c
- 04/27/22
- Kraft Heinz reports Q1 EPS 60c, consensus 53c
- 04/26/22
- Notable companies reporting before tomorrow's open
- 02/16/22
- Kraft Heinz reports Q4 adjusted EPS 79c, consensus 63c
- 05/26/22
- JetBlue sees Q2 revenue up at top end of guidance, 16% or higher
- 04/26/22
- JetBlue reports Q1 EPS (80c), consensus ((87c)
- 04/25/22
- Notable companies reporting before tomorrow's open
- 05/12/22
- Figs sees FY22 revenue $510M-$530M, consensus $556.53M
- 05/12/22
- Figs reports Q1 adjusted EPS 5c, consensus 6c
- 03/08/22
- Figs sees FY22 revenue $550M-$560M, consensus $547.3M
- 03/08/22
- Figs reports Q4 adjusted EPS 9c, consensus 3c
- 04/27/22
- Equinix sees FY22 revenue $7.29B-$7.34B, consensus $7.24B
- 04/27/22
- Equinix raises FY22 AFFO view to $28.93-$29.26 from $28.87-$29.20
- 04/27/22
- Equinix sees Q2 revenue $1.81B-$1.83B, consensus $1.79B
- 04/27/22
- Equinix reports Q1 adjusted FFO $7.16, consensus $7.19
- 04/28/22
- Digital Realty backs 2021 core FFO view $6.80-$6.90, consensus $6.88
- 04/28/22
- Digital Realty reports Q1 core FFO $1.67, consensus $1.67
- 02/17/22
- Digital Realty sees FY22 core FFO $6.80-$6.90, consensus $6.90
- 02/17/22
- Digital Realty reports Q4 core FFO $1.67, consensus $1.68
DCT Duck Creek Technologies - 06/29/22
- Duck Creek Technologies sees FY22 EPS 9c-10c, consensus 10c
- 06/29/22
- Duck Creek Technologies sees Q4 EPS 1c-2c, consensus 2c
- 06/29/22
- Duck Creek Technologies reports Q3 EPS 1c, consensus 0c
- 04/01/22
- Duck Creek Technologies reports Q2 non-GAAP EPS 4c, consensus 1c
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 05/10/22
- Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year
- 05/10/22
- Coinbase reports Q1 revenue $1.165B, consensus $1.48B
- 05/10/22
- Notable companies reporting after market close
- 02/24/22
- Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y
- 06/20/22
- Fly Intel: Top five weekend stock stories
- 04/28/22
- Comcast reports Q1 adjusted EPS 86c, consensus 80c
- 04/27/22
- Notable companies reporting before tomorrow's open
- 04/20/22
- Crown Castle sees FY22 AFFO $7.31-$7.41, consensus $7.35
- 04/20/22
- Crown Castle reports Q1 EPS 97c, consensus 94c
- 01/26/22
- Crown Castle sees FY22 AFFO $7.31-$7.41, consensus $7.37
- 01/26/22
- Crown Castle reports Q4 AFFO $1.77, consensus $1.71
- 05/02/22
- Brixmor narrows FY22 NAREIT FFO view to $1.88-$1.95 from $1.86-$1.95
- 05/02/22
- Brixmor reports Q1 NAREIT FFO 49c, consensus 47c
- 02/07/22
- Brixmor sees FY21 NAREIT FFO $1.86-$1.95, consensus $1.90
- 02/07/22
- Brixmor reports Q4 NAREIT FFO 46c, consensus 46c
- 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
- 03/30/22
- BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year
- 06/30/22
- Acuity Brands reports Q3 adjusted EPS $3.52, consensus $2.96
- 04/05/22
- Acuity Brands reports Q2 adjusted EPS $2.57, consensus $2.37
- 05/03/22
- AMD raises FY22 revenue view to $26.3B from $21.5B, consensus $25.15B
- 05/03/22
- AMD sees Q2 revenue $6.5B, plus or minus $200M, consensus $6.38B
- 05/03/22
- AMD reports Q1 EPS $1.13, consensus 91c
- 05/03/22
- Notable companies reporting after market close
- 05/02/22
- Acadia Realty Trust raises FY22 FFO view to $1.17-$1.32 from $1.15-$1.31
- 05/02/22
- Acadia Realty Trust reports Q1 FFO before items 33c, consensus 29c
- 02/15/22
- Acadia sees FY22 FFO before special items $1.15-$1.31, consensus $1.22
- 02/15/22
- Acadia Realty Trust reports Q4 FFO before special items 28c, consensus 27c
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 06/29/22
- Xerox: CEO John Visentin has passed away, Steve Bandrowczak named Interim CEO
- 06/03/22
- Xerox appoints Joanne Collins Smee as EVP, president, Americas
- 05/25/22
- Xerox company CareAR enters metaverse partnership with Infosys
- 05/24/22
- Omnicom names Brian Clayton as Chief Data Privacy Officer
WBA Walgreens Boots Alliance - 06/28/22
- NeuroMetrix appoints Fluegel to board of directors
- 06/28/22
- Walgreens Boots Alliance ends strategic review, to keep ownership of Boots unit
- 06/28/22
- Walgreens Boots Alliance to retain ownership of Boots business, ends review
- 06/26/22
- Fly Intel: Top five weekend stock stories
- 05/05/22
- Ventas sees Q2 normalized FFO 69c-73c
- 04/25/22
- Ventas says Land & Buildings has withdrawn nomination of Litt for board
- 04/25/22
- Ventas shareholder Land & Buildings issues statement regarding its campaign
- 04/20/22
- Ventas says Glass Lewis recommends shareholders vote for directors
- 04/20/22
- Telefonica Brasil trading resumes
- 04/20/22
- Telefonica Brasil trading halted, news pending
- 06/30/22
- Universal Health drops 7% to $99.00 after FY22 guidance lowered
- 04/26/22
- Universal Health falls -11.4%
- 04/26/22
- Universal Health falls -11.8%
- 04/25/22
- Universal Health drops 10% to $125.00 after Q1 EPS misses estimates
STZ.B Constellation Brands; also tag STZ - $293.00 /
+22.51 (+8.32%) - 04/08/22
- Constellation Brands CEO: Our products meet the needs of our consumers
- 04/07/22
- Constellation Brands announces accelerated stock buyback
- 06/30/22
- Constellation Brands enters agreement to eliminate Class B common stock
- 06/30/22
- Constellation Brands CEO 'pleased' with 'strong start' to fiscal year
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 04/12/22
- Constellation Brands director Fowden sells $1.8M in company shares
- 05/09/22
- Simon Property raises quarterly dividend 21.4%, authorizes $2B buyback program
- 02/07/22
- Simon Property reports occupancy was 93.4% at December 31, 2021
- 06/29/22
- SGH to acquire Stratus for $225M upfront payment, with up to $50M earnout
- 06/29/22
- SGH to acquire Stratus Technologies
- 05/02/22
- CreeLED files patent infringement suit against Star Headlight & Lantern
- 04/05/22
- SGH falls over 5% to $22.00 after Q2 earnings and guidance
- 02/03/22
- Sienna Senior Living forms joint venture with Sabra Health Care
- 02/03/22
- Extendicare to sell Esprit retirement communities for $307.5M
- 06/29/22
- Spirit Airlines intends to open, immediately adjourn Special Meeting of holders
- 06/29/22
- JetBlue tells crew Spirit will 'need to reconsider' if holders vote down deal
- 06/29/22
- JetBlue issues open letter to Spirit shareholders regarding Frontier deal
- 06/28/22
- Spirit Airlines: JetBlue offer doesn't address regulatory, board's concerns
- 05/11/22
- IBM, SAP announce expansion of technology partnership
- 05/10/22
- Qualtrics and SAP partner to bring more 'empathy' to contact center
- 05/04/22
- Google Cloud and SAP launch native integration between Workspace and S/4HANA C
- 04/22/22
- SAP backs FY22 cloud revenue view up 23%-26%
- 04/06/22
- RPT Realty acquires The Crossings shopping center for $104M
- 01/06/22
- RPT Realty announces $791M of investment activity in 2021
- $212.00 /
-25.5 (-10.74%) - 06/30/22
- RH falls -11.1%
- 06/30/22
- RH falls -8.2%
- 06/29/22
- RH falls 5% to $225 after cutting FY22 revenue guidance
- 06/02/22
- RH authorizes additional $2B in share repurchases
- 06/23/22
- Supreme Court strikes down New York gun carrying restrictions
- 06/02/22
- FBI reports 2.34M NICS firearm background checks in May
- 03/23/22
- AMMO announces delivery of donated ammunition to Ukraine
- 03/17/22
- AMMO announces plans to provide crypto currency capabilities for GunBroker.com
- 06/09/22
- Poshmark director sells $1.0M in common stock
- 06/09/22
- Poshmark set to join Russell 3000 Index
- 05/22/22
- Fly Intel: Top five weekend stock stories
- 04/12/22
- Affirm, Poshmark announce two-year extension of partnership
- 06/30/22
- Pfizer submits NDA to FDA for PAXLOVID
- 06/29/22
- Pfizer/BioNTech enter new $3.2B deal with U.S. government on COVID vaccines
- 06/28/22
- Pfizer and Roivant Sciences unveil Priovant Therapeutics
- 06/27/22
- Medtronic names Pfizer executive Lidia Fonseca as new director
- 02/28/22
- Omega Healthcare, MyndVR announce strategic partnership
- 02/02/22
- Omega Healthcare not providing FY22 earnings guidance amid pandemic
- 01/27/22
- Omega Healthcare authorizes new three-year $500M buyback program
- 06/30/22
- Novartis says data show tislelizumab significantly extended median OS in ESCC
- 06/24/22
- Novartis granted orphan status for malignant glioma treatment
- 06/24/22
- Novartis receives positive CHMP opinion for Scemblix
- 06/23/22
- Novartis says FDA grants accelerated approval for Tafinlar + Mekinist
- 05/11/22
- Kite Realty Group increases quarterly dividend 5%
- 06/28/22
- Kraft Heinz announces 12-year virtual power purchase agreement with Repsol
- 05/26/22
- 3G Capital holds 7.9% of Kraft Heinz shares after share distribution
- 05/18/22
- Kraft Heinz CEO sells $11.5M in common stock
- 05/13/22
- CFTC settles enforcement action against Kraft, Mondelez
- 05/19/22
- Highwoods Properties sells FBI Tampa Field Office for $70.4M
- 05/09/22
- Highwoods Properties acquires two properties in Charlotte
- 03/07/22
- Highwoods Properties announces recent leasing activity in Tampa
- $2,195.00 /
-40.56 (-1.81%) - 06/28/22
- Pinterest confirms Bill Ready as new CEO
- $2,203.00 /
-35.42 (-1.58%) - 06/30/22
- Samsung launches Gaming Hub for Samsung Smart TVs
- 06/28/22
- J.B. Hunt, Waymo add Wayfair to autonomous trucking pilot in Texas
- 06/27/22
- Google says Hangouts to shut down in November
- 06/23/22
- Google debuts five new features for Chrome on iOS
- 05/13/22
- Figs falls -25.8%
- 05/13/22
- Figs falls -23.0%
- 05/13/22
- Figs falls -23.8%
- 05/12/22
- Figs reports active customers up 31.1% to 2M at March 31
- 05/19/22
- Equinix highlights latest progress on ESG commitments
- 03/18/22
- Equinix to acquire four Entel data centers for $705M
- 02/24/22
- Equinix names Nicole Collins as Chief Transformation Officer
- 02/07/22
- Equinix opens new IBX data center in Aschheim
- 06/28/22
- Digital Realty partners with HPE GreenLake
- 06/13/22
- Digital Realty, Mivne Real Estate form joint venture
- 06/06/22
- Digital Realty appoints Mary Hogan Preusse as chairman of board
- 05/12/22
- Digital Realty contracts for 158MW of renewable energy in California and Georgia
DCT Duck Creek Technologies - 06/28/22
- Duck Creek Technologies to acquire Prima XL, terms undisclosed
- 06/14/22
- Duck Creek Technologies highlights partnership with ODB by MCG
- 06/01/22
- Duck Creek Technologies joins Microsoft Azure Marketplace
- 05/11/22
- Duck Creek transitions Distinguished Programs to cloud native SaaS solution
- 06/24/22
- Cytokinetics announces FDA committee date to review omecamtiv mecarbil NDA
- 06/17/22
- Cytokinetics provides regulatory update for omecamtiv mecarbil
- 06/16/22
- Cytokinetics announces start of OLE study for patients completing COURAGE-ALS
- 06/13/22
- Cytokinetics announces additional data from REDWOOD-HCM
- 06/30/22
- Culp, Inc. falls -15.0%
- 06/30/22
- Culp, Inc. falls -10.1%
- 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/24/22
- Coinbase Derivatives Exchange launching crypto derivatives product
- 06/23/22
- Coinbase says investigating connectivity issues
- 06/23/22
- Coinbase to begin sunsetting Coinbase Pro later this year
- 06/15/22
- Crypto names fall again as bitcoin extends decline to $20,000
- 05/27/22
- Canopy Growth expects to be adjusted EBITDA positive in FY24
- 05/18/22
- Canopy Growth announces plans to acquire Jetty Extracts
- 04/26/22
- Canopy Growth expects to generate savings of $100M-$150M within 12-18 months
- 04/26/22
- Canopy Growth announces cost reduction initiatives including headcount reduction
- 03/02/22
- Crown Castle announces proposed offering of senior notes
- 02/09/22
- Crown Castle increasing annual dividend 50% to 12c per share
- 01/06/22
- T-Mobile, Crown Castle expand relationship with tower, small cell agreement
- 06/27/22
- WeWork appoints Hurwitz to board of directors
- $150.93 /
+8.855 (+6.23%) - 06/25/22
- Pfizer, BioNTech announce data evaluating omicron-adapted vaccine candidates
- 06/23/22
- BioNTech receives PRIME designation for BNT211 in testicular cancer
- 06/23/22
- BioNTech starts construction on first mRNA vaccine facility in Africa
- 06/30/22
- Acuity Brands jumps 9% to $170.00 after Q3 results beat estimates
- 06/30/22
- Acuity Brands reports net cash from operating activities $165.7M
- 06/23/22
- Acuity Brands falls -5.2%
- 04/07/22
- Acuity Brands appoints Sankpal as SVP, Growth, Transformation
- 06/22/22
- AMD appoints Mathew Hein as chief strategy officer
- 06/12/22
- Fly Intel: Top five weekend stock stories
- 06/10/22
- AMD CEO: We're laser focused on technology leadership
- 06/09/22
- AMD announces Technology and Product Portfolio updates
- 02/15/22
- Acadia Realty Trust raises quarterly dividend 20% to 18c per share
WBA Walgreens Boots Alliance - 06/25/22 Barclays
- Walgreens Boots Alliance price target lowered to $45 from $50 at Barclays
- 04/12/22 Cowen
- Walgreens Boots Alliance price target lowered to $50 from $55 at Cowen
- 04/05/22 Deutsche Bank
- Walgreens price target lowered to $46 from $52 at Deutsche Bank
- 04/05/22 UBS
- Walgreens Boots Alliance price target lowered to $49 from $52 at UBS
- 06/29/22 Evercore ISI
- Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
- 06/22/22 Piper Sandler
- Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 06/03/22 Oppenheimer
- Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
- $150.93 /
+8.855 (+6.23%) - 04/12/22 H.C. Wainwright
- BioNTech price target lowered to $298 from $339 at H.C. Wainwright
- 04/11/22 H.C. Wainwright
- H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
- 04/05/22 Canaccord
- BioNTech price target lowered to $300 from $450 at Canaccord
- 06/28/22 Goldman Sachs
- Constellation Brands to beat sales estimates in Q1, says Goldman Sachs
- 06/28/22 Goldman Sachs
- Boston Beer downgraded to Sell from Neutral at Goldman Sachs
- 06/24/22 Barclays
- Constellation Brands price target lowered to $272 from $283 at Barclays
- 06/21/22 UBS
- Constellation Brands price target lowered to $270 from $285 at UBS
STZ.B Constellation Brands; also tag STZ - $293.00 /
+22.51 (+8.32%) - 05/18/22 Bernstein
- Bernstein upgrades Monster Beverage to Outperform, raises price target to $110
- 01/04/22 Wells Fargo
- Constellation Brands price target raised to $300 from $265 at Wells Fargo
- 06/16/22 Loop Capital
- Loop starts Universal Health at Hold on behavioral health staffing concerns
- 06/16/22 Loop Capital
- Universal Health initiated with a Hold at Loop Capital
- 05/03/22 Mizuho
- Universal Health price target lowered to $153 from $164 at Mizuho
- 04/28/22 Wells Fargo
- Universal Health price target lowered to $118 from $139 at Wells Fargo
- $212.00 /
-25.5 (-10.74%) - 06/30/22 Morgan Stanley
- RH price target lowered to $350 from $385 at Morgan Stanley
- 06/30/22 Jefferies
- RH price target lowered to $400 from $520 at Jefferies
- 06/30/22 Wedbush
- RH price target lowered to $274 from $315 at Wedbush
- 06/30/22 Cowen
- RH price target lowered to $300 from $450 at Cowen
- 06/29/22 Deutsche Bank
- Novartis price target lowered to CHF 75 from CHF 80 at Deutsche Bank
- 05/13/22 Piper Sandler
- Point Biopharma price target lowered to $14 from $17 at Piper Sandler
- 05/13/22 Jefferies
- Roche downgraded to Hold from Buy at Jefferies
- 04/22/22 Citi
- Xerox price target lowered to $15 from $17 at Citi
- 02/24/22 Gordon Haskett
- Icahn could take Xerox private 'without breaking a sweat,' says Gordon Haskett
- 11/23/21 Gordon Haskett
- Gordon Haskett highlights Tyson, Xerox after Ericsson-Vonage deal
- 07/02/21 Bernstein
- HP plus Xerox 'consolidation math compelling,' says Bernstein
- $2,203.00 /
-35.42 (-1.58%) - 06/30/22 Wedbush
- Alphabet, Huntington removed from Best Ideas List at Wedbush
- 06/29/22 JPMorgan
- Alphabet price target lowered to $2,800 from $3,200 at JPMorgan
- 06/29/22 Redburn
- Microsoft initiated with a Buy at Redburn
- 06/21/22 Truist
- Magnite well positioned to partner with Netflix, says Truist
- $2,195.00 /
-40.56 (-1.81%) - 06/30/22 JMP Securities
- Alphabet price target lowered to $3,200 from $3,300 at JMP Securities
- 06/22/22 BMO Capital
- Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
- 05/26/22 UBS
- UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
- 05/26/22 UBS
- Kraft Heinz downgraded to Sell from Neutral at UBS
- 05/09/22 BofA
- Coca-Cola, Kraft Heinz added to 'US 1' list at BofA
- 04/19/22 Berenberg
- Tesco price target lowered to 320 GBp from 327 GBp at Berenberg
- 10/20/21 Berenberg
- Tesco price target raised to 308 GBp from 280 GBp at Berenberg
- 10/13/21 Morgan Stanley
- Tesco price target raised to 318 GBp from 303 GBp at Morgan Stanley
- 10/07/21 JPMorgan
- Tesco price target raised to 330 GBp from 300 GBp at JPMorgan
- 06/27/22 Goldman Sachs
- Coinbase downgraded to Sell from Neutral at Goldman Sachs
- 06/23/22 Redburn
- Coinbase downgraded to Neutral from Buy at Redburn
- 06/22/22 BTIG
- Coinbase price target lowered to $290 from $380 at BTIG
- 06/22/22 Mizuho
- Coinbase trading patterns show potential 'crypto fatigue,' says Mizuho
- 06/29/22 Raymond James
- Figs initiated with a Strong Buy at Raymond James
- 05/16/22 Barclays
- Figs price target lowered to $13 from $34 at Barclays
- 05/16/22 Oppenheimer
- Figs price target lowered to $22 from $45 at Oppenheimer
- 05/16/22 BofA
- Figs downgraded to Neutral from Buy at BofA
- 06/27/22 Evercore ISI
- Spirit Airlines price target raised to $28 from $25 at Evercore ISI
- 06/23/22 Raymond James
- Frontier Group upgraded to Outperform from Market Perform at Raymond James
- 06/10/22 JPMorgan
- Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
- 05/05/22 Deutsche Bank
- Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
- 06/27/22 Evercore ISI
- Frontier Group price target lowered to $15 from $20 at Evercore ISI
- 04/11/22 MKM Partners
- JetBlue upgraded to Neutral at MKM Partners on valuation
- 06/30/22 BofA
- Telefonica Brasil upgraded to Buy from Neutral at BofA
- 06/08/22 New Street
- Telefonica Brasil downgraded to Neutral from Buy at New Street
- 04/18/22 Citi
- Telefonica Brasil initiated with a Neutral at Citi
- 04/07/22 Scotiabank
- Scotiabank downgrades Telefonica Brasil, says 'no longer a bargain'
- 06/30/22 Piper Sandler
- Piper says Cytokinetics pullback due to Street 'misunderstanding' financing
- 06/17/22 H.C. Wainwright
- H.C. Wainwright says confidence in approval of Cytokinetics' omecamtiv unchanged
- 06/17/22 Piper Sandler
- Cytokinetics PDUDA extension 'not a big deal,' says Piper Sandler
- 06/09/22 Piper Sandler
- Cytokinetics price target raised to $72 from $50 at Piper Sandler
- 06/30/22 Piper Sandler
- Canopy Growth price target lowered to $3 from $4 at Piper Sandler
- 06/29/22 MKM Partners
- Canopy Growth price target lowered to C$13 from C$17 at MKM Partners
- 06/08/22 BMO Capital
- Canopy Growth downgraded to Underperform from Market Perform at BMO Capital
- 06/08/22 Barclays
- Canopy Growth price target lowered to $3.50 from $6 at Barclays
- 06/30/22 Needham
- SGH price target lowered to $40 from $45 at Needham
- 06/30/22 Stifel
- SGH price target lowered to $32 from $45 at Stifel
- 06/30/22 Deutsche Bank
- SGH price target lowered to $32 from $40 at Deutsche Bank
- 06/30/22 Barclays
- SGH price target lowered to $22 from $30 at Barclays
- 06/27/22 Credit Suisse
- Acuity Brands price target lowered to $211 from $241 at Credit Suisse
- 06/23/22 William Blair
- William Blair downgrades Acuity Brands after survey points to weaker demand
- 06/23/22 William Blair
- Acuity Brands downgraded to Market Perform from Outperform at William Blair
- 06/17/22 Baird
- Acuity Brands price target lowered to $188 from $210 at Baird
- 08/17/21 Lake Street
- AMMO price target raised to $12 at Lake Street after beat and raise report
DCT Duck Creek Technologies - 06/30/22 RBC Capital
- Duck Creek Technologies price target lowered to $18 from $25 at RBC Capital
- 06/30/22 Raymond James
- Duck Creek Technologies price target lowered to $18 from $24 at Raymond James
- 06/30/22 Barclays
- Duck Creek Technologies price target lowered to $21 from $25 at Barclays
- 04/04/22 Wolfe Research
- Duck Creek Technologies downgraded to Peer Perform at Wolfe Research
- 06/30/22 Northland
- AMD upgraded to Outperform at Northland following multiple compression
- 06/30/22 Northland
- AMD upgraded to Outperform from Market Perform at Northland
- 06/29/22 BofA
- AMD price target lowered to $110 from $160 at BofA
- 06/22/22 Morgan Stanley
- AMD resumed with an Overweight at Morgan Stanley
- 06/29/22 Raymond James
- Poshmark downgraded to Market Perform from Outperform at Raymond James
- 06/28/22 Stifel
- Poshmark price target raised to $13 from $12 at Stifel
- 06/09/22 Goldman Sachs
- Poshmark price target lowered to $12 from $14 at Goldman Sachs
- 06/01/22 JMP Securities
- Poshmark resumed with Market Perform from Outperform at JMP Securities
- 06/30/22 Jefferies
- Ventas upgraded to Buy from Hold at Jefferies
- 06/22/22 Credit Suisse
- Ventas initiated with an Outperform at Credit Suisse
- 06/03/22 Capital One
- Ventas reinstated with Overweight from Equalweight at Capital One
- 05/20/22 RBC Capital
- Ventas price target raised to $63 from $62 at RBC Capital
- 06/30/22 Jefferies
- Crown Castle upgraded to Buy from Hold at Jefferies
- 06/28/22 Deutsche Bank
- Crown Castle downgraded to Hold from Buy at Deutsche Bank
- 06/02/22 Wells Fargo
- Wells Fargo cuts Crown Castle to Underweight as growth gap versus peers widens
- 06/02/22 Wells Fargo
- Crown Castle downgraded to Underweight from Equal Weight at Wells Fargo
- 06/30/22 Jefferies
- Equinix upgraded to Buy from Hold at Jefferies
- 06/30/22 JPMorgan
- JPMorgan remains positive on data center industry after short call
- 06/29/22 Cowen
- Cowen 'largely disagrees' with Chanos' short thesis on data centers
- 05/26/22 BMO Capital
- Equinix price target lowered to $770 from $825 at BMO Capital
- 06/30/22 Jefferies
- Digital Realty upgraded to Buy from Hold at Jefferies
- 06/15/22 Deutsche Bank
- Digital Realty upgraded on 'numerous secular tailwinds' at Deutsche Bank
- 06/30/22 Jefferies
- Acadia Realty Trust downgraded to Hold at Jefferies among REIT rating shake-up
- 06/30/22 Jefferies
- Acadia Realty Trust downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Acadia Realty Trust price target lowered to $23 from $25 at Compass Point
- 06/21/22 Truist
- Acadia Realty Trust price target lowered to $23 from $27 at Truist
- 06/30/22 Jefferies
- Brixmor downgraded to Underperform from Hold at Jefferies
- 06/22/22 Credit Suisse
- Brixmor initiated with an Outperform at Credit Suisse
- 06/22/22 JPMorgan
- Brixmor upgraded to Overweight from Neutral at JPMorgan
- 06/21/22 Truist
- Brixmor price target lowered to $26 from $29 at Truist
- 06/30/22 Jefferies
- Kite Realty Group downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Kite Realty Group price target lowered to $27 from $30 at Compass Point
- 01/13/22 Baird
- Kite Realty Group upgraded to Outperform from Neutral at Baird
- 10/27/21 Jefferies
- Kite Realty Group initiated with a Buy at Jefferies
- 06/30/22 Jefferies
- Omega Healthcare downgraded to Hold from Buy at Jefferies
- 06/14/22 Truist
- Omega Healthcare price target lowered to $30 from $33 at Truist
- 06/03/22 Capital One
- Omega Healthcare reinstated with an Equalweight at Capital One
- 04/26/22 Barclays
- Omega Healthcare initiated with an Equal Weight at Barclays
- 06/30/22 Jefferies
- Sabra Health Care downgraded to Hold from Buy at Jefferies
- 06/03/22 Capital One
- Sabra Health Care reinstated with an Equalweight at Capital One
- 05/25/22 Mizuho
- Sabra Health Care upgraded to Buy from Neutral at Mizuho
- 06/30/22 Jefferies
- RPT Realty downgraded to Hold from Buy at Jefferies
- 06/22/22 Credit Suisse
- RPT Realty initiated with an Outperform at Credit Suisse
- 10/14/21 Mizuho
- RPT Realty initiated with a Buy at Mizuho
- 10/06/21 Deutsche Bank
- RPT Realty price target lowered to $16 from $17 at Deutsche Bank
- 06/30/22 Jefferies
- Simon Property downgraded to Hold at Jefferies among REIT rating shake-up
- 06/30/22 Jefferies
- Simon Property downgraded to Hold from Buy at Jefferies
- 06/22/22 Compass Point
- Simon Property price target lowered to $160 from $200 at Compass Point
- 06/03/22 Truist
- Simon Property price target lowered to $130 from $155 at Truist
- 06/30/22 Jefferies
- Highwoods Properties downgraded to Hold from Buy at Jefferies
- 06/30/22 Truist
- Highwoods Properties price target lowered to $42 from $48 at Truist
- 06/22/22 Credit Suisse
- Highwoods Properties initiated with a Neutral at Credit Suisse
- 04/22/22 Mizuho
- Highwoods Properties initiated with a Neutral at Mizuho
- 06/30/22 William Blair
- William Blair upgrades ShotSpotter with 60% upside over two years
- 06/30/22 William Blair
- ShotSpotter upgraded to Outperform from Market Perform at William Blair
- 02/23/22 Lake Street
- ShotSpotter price target lowered to $29 from $42 at Lake Street
- 12/21/21 JMP Securities
- ShotSpotter resumed with a Market Perform at JMP Securities
- 06/30/22 Exane BNP Paribas
- SAP downgraded to Neutral on near-term risks at BNP Paribas
- 06/30/22 Exane BNP Paribas
- SAP downgraded to Neutral from Outperform at Exane BNP Paribas
- 06/20/22 Jefferies
- SAP price target lowered to EUR 110 from EUR 120 at Jefferies
- 05/05/22 Grupo Santander
- SAP upgraded to Neutral from Underperform at Grupo Santander
- 04/21/22
- Xerox still sees 2022 revenue at least $7.1B, consensus $7.05B
- 04/21/22
- Xerox reports Q1 adjusted EPS (12c), consensus 13c
- 01/25/22
- Xerox sees FY22 revenue 'at least $7.1B in actual currency,' consensus $7B
- 01/25/22
- Xerox reports Q4 adjusted EPS 34c, consensus 33c
WBA Walgreens Boots Alliance - 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 06/30/22
- Walgreens Boots Alliance reports Q3 adjusted EPS 96c, consensus 92c
- 06/29/22
- Notable companies reporting before tomorrow's open
- 05/05/22
- Ventas reports Q1 normalized FFO 79c, consensus 77c
- 02/17/22
- Ventas sees Q1 normalized FFO 76c-80c, consensus 71c
- 02/17/22
- Ventas reports Q4 normalized FFO 73c, consensus 71c
- 04/28/22
- Frontier Group sees Q2 pre-tax margin between 1%-5%
- 04/28/22
- Frontier Group reports Q1 EPS (56c), consensus (43c)
- 02/07/22
- Frontier Group is not providing guidance
- 02/07/22
- Frontier Group is not providing guidance
- 06/30/22
- Universal Health cuts FY22 adjusted EPS view to $9.60-$10.40 from $11.90-$12.90
- 06/30/22
- Universal Health sees Q2 adjusted EPS $2.05-$2.15, consensus $2.79
- 04/25/22
- Universal Health reports Q1 adjusted EPS $2.15, consensus $2.46
- 04/25/22
- Notable companies reporting after market close
- 06/30/22
- Constellation Brands affirms 2023 comparable EPS view $11.20-$11.50
- 06/30/22
- Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.90
- 06/30/22
- Constellation Brands reports Q1 comparable EPS $2.66, consensus $2.52
- 02/22/22
- ShotSpotter raises FY22 revenue view to $81M-$83M from $71M-$73M
- 02/22/22
- ShotSpotter reports Q4 adjusted EPS (12c), consensus 0c
- 05/09/22
- Simon Property raises FY22 comparable FFO/share view to $11.60-$11.75
- 05/09/22
- Simon Property reports Q1 FFO/share $2.78, consensus $2.73
- 02/07/22
- Simon Property sees FY22 FFO $11.50-$11.70, consensus $11.69
- 02/07/22
- Simon Property reports Q4 FFO $3.09, consensus $2.88
- 06/29/22
- SGH sees Q4 adjusted EPS 65c, plus or minus 10c, consensus 84c
- 06/29/22
- SGH reports Q3 adjusted EPS 87c, consensus 75c
- 04/05/22
- SGH sees Q3 EPS 67c-83c, consensus 71c
- 04/05/22
- SGH reports Q2 EPS 87c, consensus 72c
- 05/04/22
- Sabra Health Care reports Q1 FFO 39c, consensus 38c
- 06/20/22
- Fly Intel: Top five weekend stock stories
- 05/04/22
- Spirit Airlines sees FY22 other capital expenditures $240M
- 05/04/22
- Spirit Airlines sees Q2 adjusted operating expenses $1.355B-$1.365B
- 05/04/22
- Spirit Airlines reports Q1 adjusted EPS ($1.60), consensus ($1.58)
- 04/22/22
- SAP reports Q1 non-IFRS EPS EUR 1.00 vs EUR 1.40 last year
- 01/27/22
- SAP reports Q4 non-IFRS EPS EUR 1.86 vs EUR 1.70 last year
- 01/13/22
- SAP sees FY22 cloud revenue EUR 11.55B-11.85B, up 23%-26%
- 01/13/22
- SAP reports Q4 EIPS EUR 1.86, up 10%
- $212.00 /
-25.5 (-10.74%) - 06/29/22
- RH cuts FY22 revenue growth view to down 5% to down 2%
- 06/29/22
- RH sees Q2 revenue down 3% to down 1%
- 06/02/22
- RH sees FY22 revenue flat to up 2%, consensus $4.01B
- 06/02/22
- RH sees Q2 revenue down (1%)-(3%), consensus $1.04B
- 06/29/22
- AMMO sees FY 23 revenue $300M -$310M, consensus $311.77M
- 06/29/22
- AMMO reports FY22 EPS 53c, consensus 35c
- 02/14/22
- AMMO backs FY22 revenue view of $250M, consensus $246.4M
- 02/14/22
- AMMO reports Q3 EPS 14c, consensus 10c
- 05/12/22
- Poshmark sees Q2 revenue $86M-$88M, consensus $89.83M
- 05/12/22
- Poshmark reports Q1 EPS (18c), consensus (22c)
- 05/12/22
- Notable companies reporting after market close
- 03/22/22
- Poshmark sees Q1 revenue $86M-$88M, consensus $90.53M
- 05/03/22
- Pfizer cuts FY22 adjusted EPS view to $6.25-$6.45 from $6.35-$6.55
- 05/03/22
- Pfizer reports Q1 adjusted EPS $1.62, consensus $1.47
- 05/02/22
- Notable companies reporting before tomorrow's open
- 05/02/22
- Omega Healthcare reports Q1 Adjusted FFO 74c, consensus 68c
- 02/02/22
- Omega Healthcare reports Q4 AFFO 77c, consensus 82c
- 04/26/22
- Novartis sees 2022 core operating income to grow mid single digit
- 04/26/22
- Novartis reports Q1 core EPS $1.46, consensus $1.46
- 02/02/22
- Novartis sees 2022 sales, core operating income up mid single digit
- 02/02/22
- Novartis reports Q4 core EPS $1.40 vs. $1.34 last year
- 02/14/22
- Kite Realty Group sees FY22 adjusted FFO $1.69-$1.75, consensus $1.62
- 02/14/22
- Kite Realty Group reports Q4 adjusted FFO 43c, consensus 37c
- 04/27/22
- Kraft Heinz reports Q1 EPS 60c, consensus 53c
- 04/26/22
- Notable companies reporting before tomorrow's open
- 02/16/22
- Kraft Heinz reports Q4 adjusted EPS 79c, consensus 63c
- $2,203.00 /
-35.42 (-1.58%) - 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 02/01/22
- Alphabet reports Q4 EPS $30.69, consensus $27.32
- 02/01/22
- Notable companies reporting after market close
- 05/12/22
- Figs sees FY22 revenue $510M-$530M, consensus $556.53M
- 05/12/22
- Figs reports Q1 adjusted EPS 5c, consensus 6c
- 03/08/22
- Figs sees FY22 revenue $550M-$560M, consensus $547.3M
- 03/08/22
- Figs reports Q4 adjusted EPS 9c, consensus 3c
- 04/27/22
- Equinix sees FY22 revenue $7.29B-$7.34B, consensus $7.24B
- 04/27/22
- Equinix raises FY22 AFFO view to $28.93-$29.26 from $28.87-$29.20
- 04/27/22
- Equinix sees Q2 revenue $1.81B-$1.83B, consensus $1.79B
- 04/27/22
- Equinix reports Q1 adjusted FFO $7.16, consensus $7.19
- 04/28/22
- Digital Realty backs 2021 core FFO view $6.80-$6.90, consensus $6.88
- 04/28/22
- Digital Realty reports Q1 core FFO $1.67, consensus $1.67
- 02/17/22
- Digital Realty sees FY22 core FFO $6.80-$6.90, consensus $6.90
- 02/17/22
- Digital Realty reports Q4 core FFO $1.67, consensus $1.68
DCT Duck Creek Technologies - 06/29/22
- Duck Creek Technologies sees FY22 EPS 9c-10c, consensus 10c
- 06/29/22
- Duck Creek Technologies sees Q4 EPS 1c-2c, consensus 2c
- 06/29/22
- Duck Creek Technologies reports Q3 EPS 1c, consensus 0c
- 04/01/22
- Duck Creek Technologies reports Q2 non-GAAP EPS 4c, consensus 1c
- 05/04/22
- Cytokinetics reports Q1 EPS ($1.05), consensus (94c)
- 02/24/22
- Cytokinetics reports Q4 EPS (36c), consensus (84c)
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 05/10/22
- Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year
- 05/10/22
- Coinbase reports Q1 revenue $1.165B, consensus $1.48B
- 05/10/22
- Notable companies reporting after market close
- 02/24/22
- Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y
- 05/27/22
- Canopy Growth reports Q4 EPS (C$1.46) vs. (C$1.85) a year ago
- 04/07/22
- Constellation Brands reports Q4 comparable EPS ex-Canopy losses $2.55
- 02/09/22
- Canopy Growth reports Q3 EPS (C$0.28) vs. (C$2.43) a year ago
- 04/20/22
- Crown Castle sees FY22 AFFO $7.31-$7.41, consensus $7.35
- 04/20/22
- Crown Castle reports Q1 EPS 97c, consensus 94c
- 01/26/22
- Crown Castle sees FY22 AFFO $7.31-$7.41, consensus $7.37
- 01/26/22
- Crown Castle reports Q4 AFFO $1.77, consensus $1.71
- 05/02/22
- Brixmor narrows FY22 NAREIT FFO view to $1.88-$1.95 from $1.86-$1.95
- 05/02/22
- Brixmor reports Q1 NAREIT FFO 49c, consensus 47c
- 02/07/22
- Brixmor sees FY21 NAREIT FFO $1.86-$1.95, consensus $1.90
- 02/07/22
- Brixmor reports Q4 NAREIT FFO 46c, consensus 46c
- $150.93 /
+8.855 (+6.23%) - 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
- 03/30/22
- BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year
- 06/30/22
- Acuity Brands reports Q3 adjusted EPS $3.52, consensus $2.96
- 04/05/22
- Acuity Brands reports Q2 adjusted EPS $2.57, consensus $2.37
- 05/03/22
- AMD raises FY22 revenue view to $26.3B from $21.5B, consensus $25.15B
- 05/03/22
- AMD sees Q2 revenue $6.5B, plus or minus $200M, consensus $6.38B
- 05/03/22
- AMD reports Q1 EPS $1.13, consensus 91c
- 05/03/22
- Notable companies reporting after market close
- 05/02/22
- Acadia Realty Trust raises FY22 FFO view to $1.17-$1.32 from $1.15-$1.31
- 05/02/22
- Acadia Realty Trust reports Q1 FFO before items 33c, consensus 29c
- 02/15/22
- Acadia sees FY22 FFO before special items $1.15-$1.31, consensus $1.22
- 02/15/22
- Acadia Realty Trust reports Q4 FFO before special items 28c, consensus 27c
|
Hot Stocks
|
Culp, Inc. is down… Culp, Inc. is down -15.0%, or -76c to $4.27. ShowHide Related Items >><< - 06/30/22
- Culp, Inc. falls -10.1%
- 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 06/29/22
- Fly Intel: After-Hours Movers
|
Hot Stocks
|
Culp, Inc. is down… Culp, Inc. is down -10.1%, or -51c to $4.52. ShowHide Related Items >><< - 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 06/29/22
- Fly Intel: After-Hours Movers
|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 06/15/22
- Zeta names Williams-Sonoma exec Silberblatt to board of directors
- 06/08/22
- Williams-Sonoma exec Ross sells 10,400 common shares
- 05/25/22
- Williams-Sonoma jumps 10.5% to $127 after Q1 earnings beat
- 05/25/22
- Williams-Sonoma reports Q1 SSS up 9.5%
- 06/29/22
- SGH to acquire Stratus for $225M upfront payment, with up to $50M earnout
- 06/29/22
- SGH to acquire Stratus Technologies
- 05/02/22
- CreeLED files patent infringement suit against Star Headlight & Lantern
- 04/05/22
- SGH falls over 5% to $22.00 after Q2 earnings and guidance
- 06/29/22
- RH falls 5% to $225 after cutting FY22 revenue guidance
- 06/02/22
- RH authorizes additional $2B in share repurchases
- 05/16/22
- Berkshire Hathaway adds Citi, exits Wells Fargo in Q1
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- 06/23/22
- Supreme Court strikes down New York gun carrying restrictions
- 06/02/22
- FBI reports 2.34M NICS firearm background checks in May
- 03/23/22
- AMMO announces delivery of donated ammunition to Ukraine
- 03/17/22
- AMMO announces plans to provide crypto currency capabilities for GunBroker.com
- 06/29/22
- MillerKnoll jumps 6% to $29.70 after Q4 results beat estimates
- 06/29/22
- MillerKnoll re-establishing share repurchase program
- 06/29/22
- MillerKnoll reports Q4 adjusted gross margin 34.8% vs. 38.1% a year ago
- 06/29/22
- MillerKnoll 'confident' in synergies target of $120M within 3 years post close
- 05/13/22
- Figs falls -25.8%
- 05/13/22
- Figs falls -23.0%
- 05/13/22
- Figs falls -23.8%
- 05/12/22
- Figs reports active customers up 31.1% to 2M at March 31
- 03/30/22
- Franklin Covey sees FY22 sees FY22 adjusted EBITDA $38M-$39M
- 01/07/22
- Franklin Covey rises 9.8%
DCT Duck Creek Technologies - 06/28/22
- Duck Creek Technologies to acquire Prima XL, terms undisclosed
- 06/14/22
- Duck Creek Technologies highlights partnership with ODB by MCG
- 06/01/22
- Duck Creek Technologies joins Microsoft Azure Marketplace
- 05/11/22
- Duck Creek transitions Distinguished Programs to cloud native SaaS solution
- 06/24/22
- Cytokinetics announces FDA committee date to review omecamtiv mecarbil NDA
- 06/17/22
- Cytokinetics provides regulatory update for omecamtiv mecarbil
- 06/16/22
- Cytokinetics announces start of OLE study for patients completing COURAGE-ALS
- 06/13/22
- Cytokinetics announces additional data from REDWOOD-HCM
- 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/14/22
- Avid launches analytical, process development suites in new facility
- 06/13/22
- Avid Bioservices announces further expansion of process development capacity
- 01/10/22
- Avid announces official opening of second downstream processing suite
AVDL Avadel Pharmaceuticals - 06/29/22
- Avadel Pharmaceuticals announces steps taken to accelerate FDA approval of FT218
- 06/03/22
- Avadel Pharmaceuticals, AASM Foundation enter exclusive YIRF collaboration
- 05/26/22
- Avadel notified by FDA of need to add certification to REMS patent to NDA
- 04/26/22
- Avadel says 'not aware of any new information' amid recent trading activity
- 06/29/22
- Angion Biomedica Corporation trading resumes
- 06/29/22
- Angion Biomedica to resume trading at 4:35 pm
- 06/29/22
- Angion Biomedica announces discontinuation of JUNIPER study
- 06/29/22
- Angion Biomedica Corporation trading halted, news pending
- 06/29/22
- Adagene announces $10M share repurchase program
- 04/08/22
- Adagene announces preclinical data on antibody candidates
- 03/31/22
- Adagene announces expected 2022 milestones, outlook
- 03/16/22
- Adagene announces FDA clearance to proceed with Phase 1b/2 trial of ADG126
- 08/17/21 Lake Street
- AMMO price target raised to $12 at Lake Street after beat and raise report
- 06/30/21 Lake Street
- AMMO price target raised to $11 from $9 at Lake Street
- 01/07/22 Barrington
- Franklin Covey price target raised to $60 from $55 at Barrington
- 11/11/21 Roth MKM
- Franklin Covey price target raised to $53 from $45 at Roth Capital
- 11/10/21 Barrington
- Franklin Covey price target raised to $55 from $45 at Barrington
- 08/19/21 Barrington
- Franklin Covey price target raised to $45 from $40 at Barrington
- 03/09/22 Craig-Hallum
- Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
- 12/08/21 RBC Capital
- Avid Bioservices price target raised to $32 from $27 at RBC Capital
- 12/08/21 Craig-Hallum
- Avid Bioservices price target raised to $35 from $29 at Craig-Hallum
- 12/08/21 KeyBanc
- Avid Bioservices downgraded to Sector Weight from Overweight at KeyBanc
- 02/01/22 Morgan Stanley
- Adagene price target lowered to $15 from $27 at Morgan Stanley
AVDL Avadel Pharmaceuticals - 05/27/22 Craig-Hallum
- Avadel Pharmaceuticals price target lowered to $15.50 from $20 at Craig-Hallum
- 05/27/22 H.C. Wainwright
- Avadel selloff yesterday 'extremely overdone', says H.C. Wainwright
- 05/26/22 Stifel
- Stifel downgrades Avadel despite 59% selloff on launch delay
- 05/26/22 Stifel
- Avadel Pharmaceuticals downgraded to Hold from Buy at Stifel
- 06/29/22 Raymond James
- Figs initiated with a Strong Buy at Raymond James
- 05/16/22 Barclays
- Figs price target lowered to $13 from $34 at Barclays
- 05/16/22 Oppenheimer
- Figs price target lowered to $22 from $45 at Oppenheimer
- 05/16/22 BofA
- Figs downgraded to Neutral from Buy at BofA
- 04/06/22 Needham
- SGH price target raised to $45 from $42.50 at Needham
- 04/06/22 Barclays
- SGH price target lowered to $30 from $35 at Barclays
- 02/08/22 Barclays
- SGH price target lowered to $35 from $82 at Barclays
- 01/10/22 Stifel
- Stifel sees 'material boost' to SGH consensus earnings from PADIS extension
DCT Duck Creek Technologies - 04/04/22 Wolfe Research
- Duck Creek Technologies downgraded to Peer Perform at Wolfe Research
- 04/01/22 Needham
- Duck Creek Technologies price target lowered to $27 from $40 at Needham
- 04/01/22 DA Davidson
- Duck Creek Technologies price target lowered to $34 from $38 at DA Davidson
- 04/01/22 Raymond James
- Duck Creek Technologies price target lowered to $24 from $36 at Raymond James
- 06/06/22 Loop Capital
- RH price target lowered to $500 from $700 at Loop Capital
- 06/06/22 Barclays
- RH price target lowered to $400 from $528 at Barclays
- 06/03/22 Jefferies
- RH price target lowered to $520 from $560 at Jefferies
- 06/03/22 Morgan Stanley
- RH price target lowered to $385 from $400 at Morgan Stanley
- 05/27/22 Barclays
- Williams-Sonoma price target lowered to $173 from $186 at Barclays
- 05/26/22 RBC Capital
- Williams-Sonoma price target lowered to $185 from $220 at RBC Capital
- 05/26/22 Morgan Stanley
- Williams-Sonoma price target lowered to $160 from $170 at Morgan Stanley
- 05/26/22 Wells Fargo
- Williams-Sonoma price target lowered to $135 from $140 at Wells Fargo
- 06/17/22 H.C. Wainwright
- H.C. Wainwright says confidence in approval of Cytokinetics' omecamtiv unchanged
- 06/17/22 Piper Sandler
- Cytokinetics PDUDA extension 'not a big deal,' says Piper Sandler
- 06/09/22 Piper Sandler
- Cytokinetics price target raised to $72 from $50 at Piper Sandler
- 05/17/22 Piper Sandler
- Piper 'surprised' AdComm called to review Cytokinetics' omecamtiv mecarbil
- 05/23/22 H.C. Wainwright
- Angion Biomedica price target lowered to $28 from $32 at H.C. Wainwright
- 04/18/22 H.C. Wainwright
- Angion Biomedica price target lowered to $32 from $50 at H.C. Wainwright
- 12/10/21 Oppenheimer
- Angion Biomedica price target lowered to $8 from $15 at Oppenheimer
- 11/09/21 H.C. Wainwright
- Angion Biomedica price target lowered to $50 from $100 at H.C. Wainwright
- 05/25/22
- Williams-Sonoma reports Q1 EPS $3.50 consensus $2.90
- 05/25/22
- Notable companies reporting after market close
- 03/16/22
- Williams-Sonoma sees FY22 performance in line with long-term outlook
- 03/16/22
- Williams-Sonoma reports Q4 adjusted EPS $5.42, consensus $4.82
- 06/29/22
- SGH sees Q4 adjusted EPS 65c, plus or minus 10c, consensus 84c
- 06/29/22
- SGH reports Q3 adjusted EPS 87c, consensus 75c
- 04/05/22
- SGH sees Q3 EPS 67c-83c, consensus 71c
- 04/05/22
- SGH reports Q2 EPS 87c, consensus 72c
- 06/29/22
- RH cuts FY22 revenue growth view to down 5% to down 2%
- 06/29/22
- RH sees Q2 revenue down 3% to down 1%
- 06/02/22
- RH sees FY22 revenue flat to up 2%, consensus $4.01B
- 06/02/22
- RH sees Q2 revenue down (1%)-(3%), consensus $1.04B
- 06/29/22
- AMMO sees FY 23 revenue $300M -$310M, consensus $311.77M
- 06/29/22
- AMMO reports FY22 EPS 53c, consensus 35c
- 02/14/22
- AMMO backs FY22 revenue view of $250M, consensus $246.4M
- 02/14/22
- AMMO reports Q3 EPS 14c, consensus 10c
- 06/29/22
- MillerKnoll sees Q1 EPS 32c-38c, consensus 35c
- 06/29/22
- MillerKnoll reports Q4 adjusted EPS 58c, consensus 47c
- 03/29/22
- MillerKnoll sees Q4 EPS 46c-52c, consensus 49c
- 03/29/22
- MillerKnoll reports Q3 adjusted EPS 28c, consensus 27c
- 06/29/22
- National Beverage reports FY22 EPS $1.69, consensus $1.75
- 03/10/22
- National Beverage reports Q3 EPS 33c, consensus 35c
- 05/12/22
- Figs sees FY22 revenue $510M-$530M, consensus $556.53M
- 05/12/22
- Figs reports Q1 adjusted EPS 5c, consensus 6c
- 03/08/22
- Figs sees FY22 revenue $550M-$560M, consensus $547.3M
- 03/08/22
- Figs reports Q4 adjusted EPS 9c, consensus 3c
- 06/29/22
- Franklin Covey reports Q3 EPS 51c, consensus 18c
- 03/30/22
- Franklin Covey reports Q2 EPS 13c, consensus 6c
- 01/06/22
- Franklin Covey backs FY22 adjusted EBITDA view $34M-$36M
- 01/06/22
- Franklin Covey backs FY22 adjusted EBITDA view $34M-$36M
DCT Duck Creek Technologies - 06/29/22
- Duck Creek Technologies sees FY22 EPS 9c-10c, consensus 10c
- 06/29/22
- Duck Creek Technologies sees Q4 EPS 1c-2c, consensus 2c
- 06/29/22
- Duck Creek Technologies reports Q3 EPS 1c, consensus 0c
- 04/01/22
- Duck Creek Technologies reports Q2 non-GAAP EPS 4c, consensus 1c
- 05/04/22
- Cytokinetics reports Q1 EPS ($1.05), consensus (94c)
- 02/24/22
- Cytokinetics reports Q4 EPS (36c), consensus (84c)
- 06/29/22
- Culp sees 1Q23 revenue comparable to 4Q22
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
- 06/29/22
- Avid Bioservices reports Q4 EPS $1.65 vs. (4c) YoY
- 06/29/22
- Avid Bioservices sees FY23 revenue $140M-$145M, consensus $146.5M
- 03/08/22
- Avid Bioservices backs FY22 revenue view $115M-$117M, consensus $116.79M
- 03/08/22
- Avid Bioservices reports Q3 EPS 4c, consensus 4c
AVDL Avadel Pharmaceuticals - 05/09/22
- Avadel Pharmaceuticals reports Q1 EPS (45c), consensus (43c)
- 03/17/22
- Avadel Pharmaceuticals reports Q4 EPS (38c), consensus (41c)
- 03/31/22
- Adagene reports 2021 non-GAAP EPS ($1.09) vs ($2.02) last year
|
Earnings
|
Due to the continued… Due to the continued volatility in the macro environment, the company is providing only limited sequential financial guidance for fiscal 2023 at this time. The company's net sales for the first quarter of fiscal 2023 are expected to be comparable to the fourth quarter of fiscal 2022. While the company still expects a material consolidated operating loss (loss from operations) for the first quarter of fiscal 2023, it expects a moderate improvement as compared to the loss incurred during the fourth quarter of fiscal 2022. The company also expects its cash position as of the end of first quarter of fiscal 2023 to be comparable to the end of fiscal 2022. ShowHide Related Items >><< - 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 06/29/22
- Culp reports Q4 EPS (49c) vs 12c last year
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
|
Earnings
|
Reports Q4 revenue… Reports Q4 revenue $56.9M, two estimates $52.49M. Commenting on the results, Iv Culp, president and chief executive officer of Culp, Inc., said, "As previously announced, our results for the fourth quarter were significantly challenged by the unexpected shutdown of our China facilities due to COVID-related restrictions affecting both of our businesses and by further weakening in domestic mattress industry sales. However, our operating loss for the quarter was somewhat less than expected, as our mattress fabrics segment experienced slightly higher sales than previously anticipated during the last two weeks of the quarter. We were also able to return a small number of employees to our CULP China locations at the end of April and facilitate product shipments in a limited capacity. Importantly, we have maintained our strong customer relationships despite this disruption. We also ended the quarter with a higher cash position than expected, with $14.6 million in cash and investments and no outstanding borrowings. In addition, we are pleased to announce the closing of our new secured credit facility, which enhances the company's financial flexibility and is expected to provide us with sufficient liquidity to navigate the ongoing headwinds." ShowHide Related Items >><< - 04/25/22
- Culp, Inc. enters into $40M credit facility
- 04/25/22
- Culp CEO says mattress fabrics sales in March and April declined materially
- 04/25/22
- Culp, Inc. sees Q4 revenue 'down significantly' from year-ago period
|